TCM
BSX icon

Tekla Capital Management’s Boston Scientific BSX Stock Holding History

Tekla Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$35.6M Buy
657,790
+91,800
+16% +$4.79M 1.39% 18
2023
Q1 		$28.3M Sell
565,990
-191,025
-25% -$9M 1.08% 27
2022
Q4 		$35M Sell
757,015
-38,200
-5% -$1.65M 1.32% 22
2022
Q3 		$30.8M Hold
795,215
– – 1.26% 24
2022
Q2 		$29.6M Buy
795,215
+225,817
+40% +$9.19M 1.16% 24
2022
Q1 		$25.2M Buy
569,398
+33,356
+6% +$1.45M 0.89% 32
2021
Q4 		$22.8M Buy
536,042
+350,111
+188% +$14.7M 0.73% 39
2021
Q3 		$8.07M Hold
185,931
– – 0.26% 83
2021
Q2 		$7.95M Hold
185,931
– – 0.26% 97
2021
Q1 		$7.19M Sell
185,931
-60,158
-24% -$2.28M 0.25% 100
2020
Q4 		$8.85M Sell
246,089
-495,207
-67% -$17.8M 0.31% 89
2020
Q3 		$28.3M Buy
741,296
+96,361
+15% +$3.71M 1.06% 23
2020
Q2 		$22.6M Buy
644,935
+57,273
+10% +$2.06M 0.86% 27
2020
Q1 		$19.2M Buy
587,662
+23,317
+4% +$911K 0.87% 26
2019
Q4 		$25.5M Sell
564,345
-605
-0.1% -$25.3K 0.97% 24
2019
Q3 		$23M Sell
564,950
-67,300
-11% -$2.85M 1% 26
2019
Q2 		$27.2M Buy
632,250
+158,631
+33% +$6.1M 1.11% 23
2019
Q1 		$18.2M Buy
473,619
+28,628
+6% +$1.09M 0.74% 34
2018
Q4 		$15.7M Hold
444,991
– – 0.67% 35
2018
Q3 		$17.1M Sell
444,991
-12,594
-3% -$440K 0.62% 40
2018
Q2 		$15M Hold
457,585
– – 0.57% 41
2018
Q1 		$12.5M Buy
457,585
+192,985
+73% +$5.25M 0.49% 47
2017
Q4 		$6.56M Buy
+264,600
New +$7.3M 0.25% 74

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Tekla Capital Management's BSX Position: Q2 2023 in Review

Tekla Capital Management increased its Boston Scientific (BSX) stake by 16% in Q2 2023, buying an estimated $4.79M and bringing the position to 657,790 shares worth $35.6M. The position accounts for 1.39% of the portfolio, ranked #18.

Tekla Capital Management first reported a position in BSX in Q4 2017 and has held it in 23 quarters since. 1,067 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

  • Tekla Capital Management held 657,790 shares of Boston Scientific worth $35.6M as of Q2 2023.
  • Tekla Capital Management bought 91,800 Boston Scientific shares in Q2 2023, an estimated $4.79M.
  • Boston Scientific made up 1.39% of Tekla Capital Management's portfolio in Q2 2023, its #18 holding.
  • Tekla Capital Management first reported a position in Boston Scientific in Q4 2017 and has held it in 23 quarters since.
  • 1,067 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.